academic article

• Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy. 2009
• Long-term control of neuropathic pain in a non-viral gene therapy paradigm..  Gene therapy.  16:470-475. 2009
• Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain. 2006
• Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain..  Pain.  126:294-308. 2006